ASTERA LABS INC. O.N. Aktie

Astera Labs reported first‑quarter 2026 revenue growth of 93% to $308.4 million, driven by demand for PCIe‑6 products, new design wins and expansion of the Scorpio family. The stock rose about 120% within six weeks after being presented as a top pick and has stabilized after a July correction thanks to further strong results. It is currently poised just below a breakout above resistance at $367, which could trigger a new buying wave. » More on deraktionaer.de

Astera Labs shares gained about 5% in premarket trading after Northland raised its rating from Market Perform to Outperform and set a $350 price target. Analysts expect positive earnings revisions and see a durable investment cycle in AI infrastructure; Astera Labs also benefits from rising rack-connectivity demand and early volume shipments of the Scorpio X series. The company reported record revenue of $392.4 million in the second quarter (+104% year/year) and adjusted earnings of $0.80 per share; management expects sequential revenue growth of around 40% for Q3. » More on de.investing.com

Astera Labs reported Q2 revenue of $392.4m (+104% y/y) and adjusted EPS of $0.80 (consensus $0.69); management guides Q3 revenue of $540–560m with a gross margin of 72% and an operating margin of 43%, implying sequential growth of about 40% and well above market consensus. The stock fell 9.1% in morning trading after a prior rally, showing a classic "sell-the-news" dynamic. Analysts raised price targets but views remain mixed, and net insider selling weighed on sentiment. The decline is company-specific; fundamental growth signals—such as early series production and a high share of PCIe‑6.0 products in revenue—remain intact. » More on de.investing.com